| Noumi Limited (NOU) ORDINARY FULLY PAID |
Consumer Staple |
$28 |
FY25 Results Announcement
|
26 Aug 2025 8:13AM |
$0.150 |
$0.100 |
fallen by
33.33%
|
|
NOU - Price-sensitive ASX Announcement
Full Release
Key Points
- Noumi Limited reported its FY25 full-year financial results, noting continued challenges from inflation and rising costs, especially in Dairy.
- The company maintained a strategic focus on brand-led growth, innovation, and operational efficiency.
- Plant segment performance remained robust with strong revenue from key brands, while the Dairy segment faced margin pressures.
- Legal and litigation matters, particularly regarding the Blue Diamond Growers dispute, were addressed with ongoing negotiations and provisions.
- A sustainability update was given, highlighting efforts in packaging, emissions reduction, and responsible sourcing.
- Noumi continued to improve capital management and strengthen its balance sheet, with a focus on cost controls and cash flow.
- The outlook for FY25 remains cautious due to persistent market headwinds, but the company is committed to repositioning for long-term growth.
- The board and management are focused on executing strategic priorities and ensuring continued compliance with regulatory requirements.
- No final dividend was declared for the year, reflecting the company’s cautious approach to capital allocation.
- The company provided a risk update, including supply chain risks, financial risks, and ongoing market uncertainty.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$4 |
Notification regarding unquoted securities - 5EA
|
26 Aug 2025 8:12AM |
$0.560 |
$0.250 |
fallen by
55.36%
|
|
| Noumi Limited (NOU) ORDINARY FULLY PAID |
Consumer Staple |
$28 |
Appendix 4E
|
26 Aug 2025 8:12AM |
$0.150 |
$0.100 |
fallen by
33.33%
|
|
NOU - Price-sensitive ASX Announcement
Full Release
Key Points
- Noumi Limited released its Appendix 4E Preliminary Final Report for the year ended 30 June 2023.
- The report contains consolidated financial data, including revenue, profit or loss after tax, and dividends.
- Operational highlights and significant events are discussed, including restructuring efforts and strategic initiatives.
- The company faced challenges such as market conditions, supply chain disruptions, and legal matters.
- The report outlines management's commentary on operations, performance, and outlook for the future.
- Detailed financial statements and notes to the accounts are included.
- The document addresses risk management and corporate governance updates.
- An independent auditor's review has been provided as part of the report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 5E Advanced Materials Inc. (5EA) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$4 |
5EA - Final Prospectus Supplement
|
26 Aug 2025 8:12AM |
$0.560 |
$0.250 |
fallen by
55.36%
|
|
| Askari Metals Limited (AS2) ORDINARY FULLY PAID |
Materials |
$7 |
Askari Metals Corporate Objectives and Activities Update
|
26 Aug 2025 8:12AM |
$0.010 |
$0.009 |
fallen by
10%
|
|
AS2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Askari Metals Limited is focused on advancing the Uis Lithium Project in Namibia.
- Ongoing technical programs include drilling and sampling to identify lithium resources.
- Strategic partnerships and potential offtake agreements are being pursued.
- Exploration continues across Askari’s Australian projects.
- The company is committed to disciplined capital management and increasing shareholder value.
- Objective to become a significant global lithium supplier is emphasized.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Botala Energy Ltd (BTE) ORDINARY FULLY PAID |
Energy |
$20 |
Application for quotation of securities - BTE
|
26 Aug 2025 8:11AM |
$0.070 |
$0.051 |
fallen by
27.14%
|
|
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$200 |
Acusensus Corporate Governance Statement and Appendix 4G
|
26 Aug 2025 8:11AM |
$0.910 |
$1.180 |
risen by
29.67%
|
|
| Bayan Mining and Minerals Limited (BMM) ORDINARY FULLY PAID |
Materials |
$7 |
Bayan Appoints Former US Official as Strategic Advisor
|
26 Aug 2025 8:11AM |
$0.245 |
$0.054 |
fallen by
77.96%
|
|
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$200 |
Acusensus FY25 Investor Presentation
|
26 Aug 2025 8:11AM |
$0.910 |
$1.180 |
risen by
29.67%
|
|
ACE - Price-sensitive ASX Announcement
Full Release
Key Points
- Acusensus Limited specializes in AI-based road safety enforcement technologies.
- The company’s flagship solution, Heads-Up, addresses illegal mobile phone use and seatbelt non-compliance.
- Acusensus has expanded its market presence internationally with contract wins in Australia, the US, UK, and other regions.
- Recurring revenue streams have grown significantly, supporting predictable financial performance.
- The FY25 outlook is focused on scaling core business, international expansion, and leveraging new product innovations.
- Operational efficiencies have improved, supporting better margins and profitability.
- Acusensus continues to invest in R&D to maintain technological leadership in road safety enforcement.
- The company is targeting additional government and private sector contracts to drive future growth.
- Commitment to shareholder value is emphasized through growth strategies and sustained technology development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$200 |
Acusensus FY25 Results Release
|
26 Aug 2025 8:11AM |
$0.910 |
$1.180 |
risen by
29.67%
|
|
ACE - Price-sensitive ASX Announcement
Full Release
Key Points
- Acusensus reported strong revenue growth for FY25, driven by international expansion.
- Substantial increase in sales in the United States and the United Kingdom markets.
- Company continued to invest in research and development for product and technology improvements.
- Secured new contracts and renewals, leading to a robust order book for FY25.
- Expanded operational team and strengthened partnerships with key stakeholders.
- Focused on cost optimization to improve profitability.
- Reaffirmed commitment to global road safety initiatives and delivering shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acusensus Limited (ACE) ORDINARY FULLY PAID |
Information Technology |
$200 |
Acusensus Appendix 4E and FY25 Annual Report
|
26 Aug 2025 8:11AM |
$0.910 |
$1.180 |
risen by
29.67%
|
|
ACE - Price-sensitive ASX Announcement
Full Release
Key Points
- Acusensus Limited reported solid revenue growth and improved financial performance for FY23.
- The company expanded its operations internationally and secured new contracts in Australia and overseas.
- Significant investment was made in research, product development, and AI-driven road safety solutions.
- The annual report details comprehensive financial results, including revenue, EBITDA, profit/loss, cash flow, and balance sheet summaries.
- Acusensus continues to prioritize innovation and technology to address road safety and enforcement challenges.
- The Board upholds strong corporate governance and risk management practices.
- Remuneration, shareholdings, and statutory compliance are transparently disclosed.
- The company is well-positioned for future growth in the global market for road safety and traffic enforcement solutions.
- Sustainability and responsible business practices are highlighted as ongoing commitments.
- Appendix 4E requirements are met, including commentary on financial performance, dividends, and audit opinions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brightstar Resources Limited (BTR) ORDINARY FULLY PAID |
Materials |
$365 |
Change of Director's Interest Notice - On Market Buying
|
26 Aug 2025 8:10AM |
$0.390 |
$0.333 |
fallen by
14.74%
|
|
| Austin Engineering Limited (ANG) ORDINARY FULLY PAID |
Industrials |
$89 |
Appendix 4E
|
26 Aug 2025 8:10AM |
$0.315 |
$0.143 |
fallen by
54.76%
|
|
ANG - Price-sensitive ASX Announcement
Full Release
Key Points
- Austin Engineering Limited reported record sales revenue for FY23.
- Strong demand in mining products and services contributed to financial growth.
- Operational improvements led to increased margins and profitability.
- Expansion of manufacturing operations in North and South America.
- Implementation of digital transformation projects to enhance efficiency and customer engagement.
- Significant increase in underlying EBITDA compared to the previous year.
- Company maintained a strong balance sheet and liquidity position.
- Improvements in workplace safety metrics achieved.
- Ongoing commitment to sustainability and ESG initiatives.
- Positive outlook for continued growth supported by strong order book and mining sector demand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firebrick Pharma Limited (FRE) ORDINARY FULLY PAID |
Health Care |
$9 |
Proposed issue of securities - FRE
|
26 Aug 2025 8:10AM |
$0.074 |
$0.031 |
fallen by
58.11%
|
|
| Robex Resources Inc. (RXR) ORDINARY FULLY PAID |
Materials |
- |
Robex Remains on Track for First Gold at Kiniero in Q4 CY202
|
26 Aug 2025 8:10AM |
$3.600 |
$7.230 |
risen by
100.83%
|
|
RXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Robex Resources Inc. is on track for first gold production at the Kiniero Gold Project in Q4 2024.
- Significant construction progress includes near-completion of CIL tanks and major civil works.
- Key equipment procurement and structural installations are advancing as planned.
- Successful recruitment and training of local operational personnel are underway.
- Robust health, safety, and environmental management protocols are in place.
- Project remains within budget and on schedule despite logistical and operational challenges.
- Active engagement with local stakeholders and communities is ongoing.
- The project will transition Robex into a mid-tier West African gold producer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$468 |
2025 Annual Report
|
26 Aug 2025 8:10AM |
$0.735 |
$0.855 |
risen by
16.33%
|
|
| Firebrick Pharma Limited (FRE) ORDINARY FULLY PAID |
Health Care |
$9 |
Firebrick Secures $1.4 million via Placement
|
26 Aug 2025 8:10AM |
$0.074 |
$0.031 |
fallen by
58.11%
|
|
FRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Firebrick Pharma Limited secured $1.4 million through a share placement.
- Funds are intended to support the commercialisation of Nasodine® Nasal Spray and provide working capital.
- The share placement was offered at $0.022 per share.
- Approximately 63.6 million new shares will be issued as part of the placement.
- The placement was targeted at sophisticated and professional investors.
- The Board thanked shareholders for their support and confidence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bega Cheese Limited (BGA) ORDINARY FULLY PAID |
Consumer Staple |
$1,809 |
Fonterra Legal Proceedings to be Discontinued
|
26 Aug 2025 8:09AM |
$5.650 |
$5.920 |
risen by
4.78%
|
|
| Vulcan Steel Limited (VSL) ORDINARY FULLY PAID |
Materials |
$703 |
Renounceable Issue
|
26 Aug 2025 8:09AM |
$6.600 |
$4.795 |
fallen by
27.35%
|
|
VSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Vulcan Steel Limited is conducting a 1 for 6 pro rata renounceable entitlement offer.
- The offer aims to raise approximately NZ$100 million and is fully underwritten.
- New shares will be issued at NZ$7.10 per share (AU$6.59 per share for Australians), at a discount to the previous trading price.
- Funds raised will be used for debt reduction, working capital, and future growth.
- The offer is open to eligible shareholders in New Zealand and Australia.
- Shareholders can choose to participate, sell their entitlements, or allow dilution.
- The offer excludes participation from shareholders in most jurisdictions outside New Zealand and Australia.
- Risks related to the offer and investment in Vulcan Steel are outlined in the document.
- Detailed terms, timetable, and instructions for participating are provided.
- The announcement date of the offer is 13 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firebrick Pharma Limited (FRE) ORDINARY FULLY PAID |
Health Care |
$9 |
License Agreement for Singapore, Malaysia, Brunei, Mauritius
|
26 Aug 2025 8:09AM |
$0.074 |
$0.031 |
fallen by
58.11%
|
|
FRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Firebrick Pharma Limited signed a License Agreement with Pharmacosmos (Asia Pacific) Pte Ltd.
- The agreement covers exclusive rights to market, sell, and distribute Nasodine® Nasal Spray in Singapore, Malaysia, Brunei, and Mauritius.
- Pharmacosmos will be responsible for obtaining regulatory approval and commercializing Nasodine in the specified regions.
- The deal includes an upfront license fee, milestone payments, and sales royalties.
- This agreement supports Firebrick's strategy to broaden the international reach of Nasodine.
- Nasodine® Nasal Spray is positioned for treating and preventing common colds and potentially reducing viral transmission.
- The agreement follows similar licensing deals Firebrick has secured in other global territories.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vulcan Steel Limited (VSL) ORDINARY FULLY PAID |
Materials |
$703 |
FY25 ASX Appendix 4G - Key to Corporate Governance Discl
|
26 Aug 2025 8:09AM |
$6.600 |
$4.795 |
fallen by
27.35%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$63,064 |
Statement of Changes in Beneficial Ownership
|
26 Aug 2025 8:09AM |
$122.290 |
$111.780 |
fallen by
8.59%
|
|
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$177 |
Update - Notification of buy-back - CAA
|
26 Aug 2025 8:09AM |
$11.010 |
$11.150 |
risen by
1.27%
|
|
| Vulcan Steel Limited (VSL) ORDINARY FULLY PAID |
Materials |
$703 |
FY25 Results, Acquisition and Equity Raising Presentation
|
26 Aug 2025 8:08AM |
$6.600 |
$4.795 |
fallen by
27.35%
|
|
VSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 10.9% YoY in FY25.
- Adjusted EBITDA fell by 24.1% compared to FY24.
- Net profit after tax decreased by 55.2% YoY.
- Acquisition of Roofing Industries Limited to expand product offerings.
- Equity raising initiative to support the acquisition.
- Focus on cross-selling opportunities and customer service.
- Continued investment in health and safety improvements.
- Challenging market conditions impacted profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$63,064 |
Statement of Changes in Beneficial Ownership
|
26 Aug 2025 8:08AM |
$122.290 |
$111.780 |
fallen by
8.59%
|
|
Call 1300 880 160
Start a chat
Schedule a call
